Subcutaneous low molecular weight heparin in place of heparin infusion during warfarin dose optimisation in cerebral ischaemia

Clinical Neurology and Neurosurgery

Volumn 100, Issue 3, 1998, Pages 193-195

  Venketasubramanian, N ^a   Chua, Hoe Chin ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

Anticoagulation; Cerebrovascular disease; Heparin; Low molecular weight heparin; Stroke; Summary; Transient ischemic attack; Warfarin

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BRAIN ISCHEMIA; CAPILLARY RESISTANCE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; OUTPATIENT; STROKE; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSIENT ISCHEMIC ATTACK;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; ANTICOAGULANTS; BRAIN ISCHEMIA; FEASIBILITY STUDIES; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INJECTIONS, SUBCUTANEOUS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; OUTPATIENTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; WARFARIN;

EID: 0031784470     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-8467(98)00039-0     Document Type: Article

References (8)

1. Hirsh J, Levine MN Low molecular weight heparin. Blood. 79:1992;1-7.
2. Kay R, Wong KS, Woo J Pilot study of low molecular weight heparin in the treatment of acute ischaemic stroke. Stroke. 25:1994;684-685.
3. Kay R, Wong KS, Yu YL, Chan YW, Tsoi TH, Ahuja AT et al. Low molecular weight heparin for the treatment of acute ischaemic stroke. New Engl J Med. 333:1995;1588-1593.
4. Matzsch T, Bergqvist D, Hedner U, Ostergaard P Effects of an enzymatically depolymerised heparin as compared with conventional heparin in healthy volunteers. Thromb Hemost. 57:1987;97-101.
5. Lee LB, Buckley MM Nadroparin calcium. Drugs. 44:1992;858-888.
6. Bonen B Low molecular weight heparin therapy: is monitoring needed? (review). Thromb Hemost. 72:1994;330-334.
7. Teo CP, Lim HL, Kueh YK Cost effectiveness and ease of administration of low molecular weight heparin in deep vein thrombosis (letter). Thromb Hemost. 72:1994;328-329.
8. Green D, Hirsh J, Heit J, Prins M, Davidson B, Lensing AW Low molecular weight heparin: a critical analysis of clinical trails (review). Pharmacol Rev. 46:1994;89-110.